Reticare is based on 15 years of research led by the Complutense University of Madrid (UCM) concerning risks of light from device screens on the retina. Backed by an extensive scientific knowledge, we develop products that prevent the consequential damages from technology usage.
Reticare is a young, contemporary company with a big mission: saving the world from a global vision crisis. Reticare is one of the worldwide main players and advisor for many governments and institutions on the topic of prevention from the risks of high energy light emitted from device screens.
Risks associated with using devices include symptoms such as headaches, eye strain and sleep disorders but, most importantly, irreversible damage to the retina proven by UCM’s studies. We are concerned about the serious risks associated with macular degeneration, the leading cause of central vision blindness in the world.
Today, more than 400,000 people, among them two Nobel Prize Winners, the U.S. Senate and the West Point Academy, use our solutions. Health organizations such as the Vision Council and specialties such as optometry, optics, ophthalmology and medicine already warn about the risks from device screens. Many recommend Reticare eye protectors to their patients.
Don’t take a chance, preserve your vision, the window to our world and our future.
500.000 individuals and hundreds of companies and institutions already use Reticare
1,500 people involved in studies
2 headquarters (USA and Spain)
2 Nobel Prize Winners as Scientific Advisors
Profound scientific evidence and knowledge about the blue light effects with over 15 years of experience
About the Complutense University of Madrid (UCM)
Top University in Spain – Ranked #1
Roster of alumni:
Nobel Prize Winners (7)
Principe de Asturias awards (18)
Miguel de Cervantes Prize (7)
European Commissioners
Presidents of the EU Parliament
European Council Secretary General
ECB Executive Board members
NATO Secretary General
UNESCO Director General
IMF Managing Director, and Heads of State
